201 related articles for article (PubMed ID: 37552290)
21. Sex-dependent differences in the anxiolytic-like effect of cannabidiol in the elevated plus-maze.
Fabris D; Carvalho MC; Brandão ML; Prado WA; Zuardi AW; Crippa JA; de Oliveira AR; Lovick TA; Genaro K
J Psychopharmacol; 2022 Dec; 36(12):1371-1383. PubMed ID: 36239039
[TBL] [Abstract][Full Text] [Related]
22. The anxiolytic effect of cannabidiol depends on the nature of the trauma when patients with post-traumatic stress disorder recall their trigger event.
Bolsoni LM; Crippa JAS; Hallak JEC; Guimarães FS; Zuardi AW
Braz J Psychiatry; 2022; 44(3):298-307. PubMed ID: 35293520
[TBL] [Abstract][Full Text] [Related]
23. Oral medicinal cannabinoids to relieve symptom burden in the palliative care of patients with advanced cancer: a double-blind, placebo-controlled, randomised clinical trial of efficacy and safety of 1:1 delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD).
Hardy J; Haywood A; Gogna G; Martin J; Yates P; Greer R; Good P
Trials; 2020 Jul; 21(1):611. PubMed ID: 32631447
[TBL] [Abstract][Full Text] [Related]
24. Effects of the Acute and Chronic Administration of Cannabidiol on Cognition in Humans and Animals: A Systematic Review.
Bomfim AJL; Zuze SMF; Fabrício DM; Pessoa RMP; Crippa JAS; Chagas MHN
Cannabis Cannabinoid Res; 2023 Dec; 8(6):955-973. PubMed ID: 37792394
[No Abstract] [Full Text] [Related]
25. Fluorinated Cannabidiol Derivatives: Enhancement of Activity in Mice Models Predictive of Anxiolytic, Antidepressant and Antipsychotic Effects.
Breuer A; Haj CG; Fogaça MV; Gomes FV; Silva NR; Pedrazzi JF; Del Bel EA; Hallak JC; Crippa JA; Zuardi AW; Mechoulam R; Guimarães FS
PLoS One; 2016; 11(7):e0158779. PubMed ID: 27416026
[TBL] [Abstract][Full Text] [Related]
26. Could Cannabidiol Be a Treatment for Coronavirus Disease-19-Related Anxiety Disorders?
O'Sullivan SE; Stevenson CW; Laviolette SR
Cannabis Cannabinoid Res; 2021; 6(1):7-18. PubMed ID: 33614948
[TBL] [Abstract][Full Text] [Related]
27. Use of Cannabidiol (CBD) oil in the treatment of PTSD: Study design and rationale for a placebo-controlled randomized clinical trial.
Telch MJ; Fischer CM; Zaizar ED; Rubin M; Papini S
Contemp Clin Trials; 2022 Nov; 122():106933. PubMed ID: 36154908
[TBL] [Abstract][Full Text] [Related]
28. The impact of cannabidiol placebo on responses to an acute stressor: A replication and proof of concept study.
Zhekova RM; Perry RN; Spinella TC; Dockrill K; Stewart SH; Barrett SP
J Psychopharmacol; 2024 Jan; 38(1):116-124. PubMed ID: 38214314
[TBL] [Abstract][Full Text] [Related]
29. Don't Fear the Reefer-Evidence Mounts for Plant-Based Cannabidiol as Treatment for Epilepsy.
Perry MS
Epilepsy Curr; 2019; 19(2):93-95. PubMed ID: 30955420
[TBL] [Abstract][Full Text] [Related]
30. Cannabidiol exhibits anxiolytic-like effects and antipsychotic-like effects in mice models.
Shu G; He Y; Suo J; Wu C; Gong X; Xiang Y; Yang W; Cheng J; Wang Y; Chen W; Shen J
Neurosci Lett; 2024 Mar; 826():137723. PubMed ID: 38467272
[TBL] [Abstract][Full Text] [Related]
31. Cannabidiol, a Cannabis sativa constituent, as an anxiolytic drug.
Schier AR; Ribeiro NP; Silva AC; Hallak JE; Crippa JA; Nardi AE; Zuardi AW
Braz J Psychiatry; 2012 Jun; 34 Suppl 1():S104-10. PubMed ID: 22729452
[TBL] [Abstract][Full Text] [Related]
32. The anxiolytic effect of cannabidiol on chronically stressed mice depends on hippocampal neurogenesis: involvement of the endocannabinoid system.
Campos AC; Ortega Z; Palazuelos J; Fogaça MV; Aguiar DC; Díaz-Alonso J; Ortega-Gutiérrez S; Vázquez-Villa H; Moreira FA; Guzmán M; Galve-Roperh I; Guimarães FS
Int J Neuropsychopharmacol; 2013 Jul; 16(6):1407-19. PubMed ID: 23298518
[TBL] [Abstract][Full Text] [Related]
33. Effect of four-week cannabidiol treatment on cognitive function: secondary outcomes from a randomised clinical trial for the treatment of cannabis use disorder.
Lees R; Hines LA; Hindocha C; Baio G; Shaban NDC; Stothart G; Mofeez A; Morgan CJA; Curran HV; Freeman TP
Psychopharmacology (Berl); 2023 Feb; 240(2):337-346. PubMed ID: 36598543
[TBL] [Abstract][Full Text] [Related]
34. A placebo-controlled investigation of the analgesic effects, abuse liability, safety and tolerability of a range of oral cannabidiol doses in healthy humans.
Arout CA; Haney M; Herrmann ES; Bedi G; Cooper ZD
Br J Clin Pharmacol; 2022 Jan; 88(1):347-355. PubMed ID: 34223660
[TBL] [Abstract][Full Text] [Related]
35. Effects of short-term cannabidiol treatment on response to social stress in subjects at clinical high risk of developing psychosis.
Appiah-Kusi E; Petros N; Wilson R; Colizzi M; Bossong MG; Valmaggia L; Mondelli V; McGuire P; Bhattacharyya S
Psychopharmacology (Berl); 2020 Apr; 237(4):1121-1130. PubMed ID: 31915861
[TBL] [Abstract][Full Text] [Related]
36. Use of cannabidiol in anxiety and anxiety-related disorders.
Skelley JW; Deas CM; Curren Z; Ennis J
J Am Pharm Assoc (2003); 2020; 60(1):253-261. PubMed ID: 31866386
[TBL] [Abstract][Full Text] [Related]
37. A behavioural comparison of acute and chronic Delta9-tetrahydrocannabinol and cannabidiol in C57BL/6JArc mice.
Long LE; Chesworth R; Huang XF; McGregor IS; Arnold JC; Karl T
Int J Neuropsychopharmacol; 2010 Aug; 13(7):861-76. PubMed ID: 19785914
[TBL] [Abstract][Full Text] [Related]
38. A narrative review of molecular mechanism and therapeutic effect of cannabidiol (CBD).
Peng J; Fan M; An C; Ni F; Huang W; Luo J
Basic Clin Pharmacol Toxicol; 2022 Apr; 130(4):439-456. PubMed ID: 35083862
[TBL] [Abstract][Full Text] [Related]
39. Cannabidiol versus placebo as adjunctive treatment in early psychosis: study protocol for randomized controlled trial.
Dixon T; Cadenhead KS
Trials; 2023 Nov; 24(1):775. PubMed ID: 38037108
[TBL] [Abstract][Full Text] [Related]
40. Absence of Evidence for Sustained Effects of Daily Cannabidiol Administration on Anandamide Plasma Concentration in Individuals with Cocaine Use Disorder: Exploratory Findings from a Randomized Controlled Trial.
Hebert FO; Mongeau-Pérusse V; Rizkallah E; Mahroug A; Bakouni H; Morissette F; Brissette S; Bruneau J; Dubreucq S; Jutras-Aswad D
Cannabis Cannabinoid Res; 2024 May; ():. PubMed ID: 38770686
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
